Friday, July 22, 2016

BRIEF-EU Medicines Agency recommends approval of two new cancer drugs

* Recommends approval of Exelixis Inc'S

cabozantinib to treat advanced renal cell carcinoma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)